 Research
 Open Access
 Published:
A polynomial based model for cell fate prediction in human diseases
BMC Systems Biology volume 11, Article number: 126 (2017)
Abstract
Background
Cell fate regulation directly affects tissue homeostasis and human health. Research on cell fate decision sheds light on key regulators, facilitates understanding the mechanisms, and suggests novel strategies to treat human diseases that are related to abnormal cell development.
Results
In this study, we proposed a polynomial based model to predict cell fate. This model was derived from Taylor series. As a case study, gene expression data of pancreatic cells were adopted to test and verify the model. As numerous features (genes) are available, we employed two kinds of feature selection methods, i.e. correlation based and apoptosis pathway based. Then polynomials of different degrees were used to refine the cell fate prediction function. 10fold crossvalidation was carried out to evaluate the performance of our model. In addition, we analyzed the stability of the resultant cell fate prediction model by evaluating the ranges of the parameters, as well as assessing the variances of the predicted values at randomly selected points. Results show that, within both the two considered gene selection methods, the prediction accuracies of polynomials of different degrees show little differences. Interestingly, the linear polynomial (degree 1 polynomial) is more stable than others. When comparing the linear polynomials based on the two gene selection methods, it shows that although the accuracy of the linear polynomial that uses correlation analysis outcomes is a little higher (achieves 86.62%), the one within genes of the apoptosis pathway is much more stable.
Conclusions
Considering both the prediction accuracy and the stability of polynomial models of different degrees, the linear model is a preferred choice for cell fate prediction with gene expression data of pancreatic cells. The presented cell fate prediction model can be extended to other cells, which may be important for basic research as well as clinical study of cell development related diseases.
Background
Many human diseases are caused by over proliferation or progressive death of specific cells [1, 2]. One notorious example that involves uncontrolled cell growth is cancer, which has become a leading killer worldwide [3]. In contrast to abnormal cell growth, excessive cell death also results in serious damage to human body. Abnormal cardiomyocyte death is a hallmark of various cardiovascular diseases (e.g. heart failure) [4, 5]. Neurodegenerative disorders, such as Parkinson’s, Alzheimer’s and Huntington’s diseases underlie the continuous death of specific neurons [6, 7]. Hepatocellular death is an indicator in detecting liver diseases [8]. Pancreatic βcell deficit is a main character of type 2 diabetes (T2D) [9, 10]. Thus, cell fate has a direct bearing on human health, and the research on cell fate decision facilitates the study of the mechanisms and may pave the way for preventing diseases caused by abnormal cell development.
With the development of biomathematics, mathematical modeling has been employed in formulating hypotheses and interpreting mechanisms of cell fate decision [11,12,13,14]. The models can be categorized according to their properties into different groups, e.g. discrete or continuous, static or dynamic, knowledgedriven or datadriven, etc. In addition, different kinds of data, such as gene expression data or protein activity data, are used in these models. Calzone et al. conceived a compact model based on logical formalization of signal transduction for cell fate decision [15]. They also applied a similar model to the study of cancer cell fate determination [16]. This logical model describes the biological processes in a mechanistic way, but it can only perform in a discrete mode and cannot incorporate contextspecific information from real data. Tyson et al. constructed a dynamic model (based on ordinary differential equations) to study cell fate of breast cancer cells [17]. Bhattacharya et al. mapped Waddington’s epigenetic landscape to visualize cell fate based on dynamics of gene regulatory network [18]. Both the dynamic model and the Waddington’s epigenetic landscape require the trajectory information of genes (i.e. timeseries gene expression data). The aforementioned three models are knowledgedriven models. As advances in experimental techniques to measure biological data and progresses of methods in computer science, datadriven models become very popular in decoding cell fate decision mechanisms. Janes et al. [19] and Lee et al. [20] employed a partial least squares (PLS) regression model to correlate protein activity levels and phenotypic responses of cancer cells. Note that, the PLS regression model is based on linear transformation. Considering the complexity of biological systems (e.g. cross talk and feedback in signaling pathways), the linear model is not convincing to some researchers. Thus, with the utilization of the same dataset in [20], Zhang et al. [21] proposed an exponential model, which performed better in predicting cell fate than the original linear model used in [20]. However, a log transformation to the protein activity data would convert the exponential model into a linear one. Although these models try to study the cell fate decision, the mechanisms remain far from clear.
We intend to build a model to predict cell fate based on singlecell gene expression data, in which a function is employed to demonstrate their relationship. In this work, cell fate is quantified as the probability of cell death. Considering that a function can be represented with Taylor series under certain conditions (i.e. it can be infinitely differentiable at a fixed point), we applied this theory and directly used different degree polynomials to fit the cell fate prediction function. The gene expression dataset was obtained from singlecell transcriptome profiling of human pancreas [22]. Overall, there are 2209 pancreatic cells from patients of T2D and healthy individuals, and a total of 26,179 genes were measured for each cell. As only a small portion of genes are closely related to cell fate decision, a feature (gene) selection step was conducted on the training data. In this study, we used a correlation based feature selection approach, as well as an apoptosis pathway based method. The correlation based method employs Spearman’s correlation analysis approach [23] to conduct gene selection, and the outcomes only depend on the relationship between gene expression data and cell fates (i.e. the polynomial model based on correlation analysis outcomes is a datadriven model). Differently, the apoptosis pathway based method directly regards the genes in the apoptosis pathway as features, and incorporates gene regulation information into the cell fate prediction model (i.e. the polynomial model within genes of the apoptosis pathway is a combination of datadriven and knowledgedriven models, also known as a hybrid model). After the selected genes were obtained, we performed a regression process to refine the cell fate prediction function, and proceeded to the prediction phase. 10fold crossvalidation was carried out to evaluate the performance of our model. Moreover, we analyzed the stability (i.e. discrepancies of the functions when the training data were changed) of the cell fate prediction functions by evaluating the ranges of the parameters as well as computing the variances of the predicted values at randomly selected points. Results show that within both the gene selection methods, linear polynomial performs better than others. When comparing the linear polynomials based on the two gene selection methods, the prediction accuracy of the model based on the correlation analysis outcomes is a little higher (86.62% vs. 84.17%) than the one using genes from the apoptosis pathway. However, the model within genes from the apoptosis pathway is more stable. The proposed polynomial model in our work demonstrates the feasibility of using linear model to predict cell fate. In addition, current datadriven models for cell fate prediction are often assessed by prediction accuracy. The stability analysis in our work provides ways for a comprehensive evaluation of these models.
Methods
Polynomial representation of cell fate
When the gene expression profile of a single cell is available, we aim to predict the fate of this cell based on the expression levels of specific genes. To illustrate our model, suppose we are given three cell fate related genes A, B, and C, with the corresponding expression levels of x _{ A }, x _{ B }, and x _{ C }, respectively. Then we build a model to associate the cell fate P (P ∈ [0, 1]) with the three genes’ expression levels. Suppose that the three genes are independent of each other, then P can be represented as:
where f, g, and h are three arbitrary functions. If f(x _{ A }) is infinitely differentiable at a (where a is a real or complex number), we can expand f(x _{ A }) with Taylor series as follows,
Here, f ^{(n)}(a) denotes the nth derivative of f(x _{ A }) at a. Similarly, g(x _{ B }) and h(x _{ C }) can be represented with Taylor series respectively. As such, P can be rewritten as:
where k _{ An }, k _{ Bn } and k _{ Cn } are polynomial coefficients, and b is a constant. In some cases, the genes are not mutually independent, e.g., gene A promotes the transcription of gene C. Then the simultaneous influence of genes A and C on cell fate P is not additive. We employ f(x _{ A }, x _{ C }) to show their synergistic effects. Accordingly, P can be represented as:
Similar to the Taylor series representation of a function with one variable (Eq. (2)), we can also expand a function with two variables. If f(x _{ A }, x _{ C }) is infinitely differentiable at a point (a, c), where a and c are real or complex values, it can be expressed with Taylor series as follows,
The subscripts of f in Eq. (5) stand for partial derivatives. Considering that g(x _{ B }) can be represented with Taylor series (similar to Eq. (2)), we can obtain the polynomial representation of P by summing up the expansions of f(x _{ A }, x _{ C })and g(x _{ B }). Finally, P is derived as
where k _{ An }, k _{ Bn }, k _{ Cn } and \( {k}_{AC}^{\prime } \) are polynomial coefficients, and b is a constant.
The above analysis is based on three genes. Now let us consider l genes (x _{1}, x _{2}, ⋯, x _{ l }) to determine the function of P, and assume all the genes are independent of each other. Then P can be derived by extending Eq. (3) as follows,
In case of related genes (gene transcription regulation), we can add the cross terms to P, i.e.,
where x _{ i } and x _{ j } represent any two related genes. In the scenario of transcription regulation involving several genes, Taylor series representation of multiple variables can be applied. In practice, we approximate Eqs. (7) and (8) with a finite number of terms. Then, with the utilization of regression methods, the function of P can be obtained, when the data of gene expression profiles and cell fates of a group of cells are available.
In this work, polynomials of different degree were employed to fit the function of P. The MATLAB function regress was carried out to conduct the regression process. This function is based on the method of least squares. Detailed information can be found in [24].
Correlation between cell fate decisions and gene expression profiles
Tens of thousands of genes are encoded in the human genome, and their products play different roles in human body [25]. Specific to cell fate, there are only a portion of genes related to it. Thus, we need to conduct a feature (gene) selection process, in order to find out the cell fate decision related genes. Correlation analysis is a common method for feature selection in machine learning. Therefore, in this study, we employed Spearman’s rank correlation analysis approach [23] to evaluate the relevance between gene expression levels and cell fates. Specifically, for a gene, we computed the Spearman’s rank correlation coefficient between this gene’s expression levels in all the cells and the corresponding cell fates. Spearman’s rank correlation measures the monotonic relationship of two variables. Given two sets of variables X and Y, the corresponding ranks of the two sets of variables are X _{ R } and Y _{ R }, respectively. Then the Spearman’s rank correlation coefficient ρ is derived by
where cov(X _{ R }, Y _{ R }) denotes the covariance of X _{ R } and Y _{ R }, \( {\sigma}_{{\boldsymbol{X}}_R} \)and \( {\sigma}_{{\boldsymbol{Y}}_R} \) represent the standard deviations of X _{ R } and Y _{ R }, respectively. After the correlation coefficient of each gene with cell fates was obtained, we sorted the genes according the absolute values of the coefficients. The highly ranked genes were considered as important for cell fate decision.
Statistical analysis
Statistical comparison of gene expression levels for two groups of samples (cells from healthy and T2D donors) was carried out by using Student’s ttest. The difference between the two groups was considered as significant if the pvalue is less than 0.05.
Results
Singlecell gene expression in pancreas
The singlecell gene expression dataset was obtained from [22]. This dataset comprises profiles of totally 2209 pancreatic cells, belonging to 10 donors. Among the donors, six were healthy while four experienced T2D. The numbers of cells obtained from the donors are shown in Fig. 1a. The human pancreas is composed of exocrine and endocrine regions, corresponding to exocrine cells and endocrine islets. Most of the exocrine cells are acinar cells or ductal cells, which play an important role in digestion by secreting and transporting digestive enzymes [26]. Endocrine islets mainly contain hormoneproducing cells, e.g. αcells, βcells, γcells, δcells, and εcells [27]. Figure 1b shows the distribution of the pancreatic cells among cell types.
In this study, we intend to predict the fate of a cell according to its gene expression data. Specifically, within its gene expression profiles, we try to predict the probability of cell death (which is represented by apoptosis in this paper). It is well known that caspases 3, 6, and 7 are executioner enzymes in apoptosis. Thus, it is reasonable to use their expression levels as markers for measuring the cell death probability. Figure 2ac present the expression levels of caspases 3, 6, and 7 in all the 2209 cells in descending order. We employed the combined expression levels of caspases 3, 6, and 7 to measure the likelihood of cell death. Then the death probability of a cell can be derived by dividing its combined expression level of caspases 3, 6, and 7 by the maximum total expression value of the 3 caspases in all the cells (Fig. 2d). In this work, a cell is considered as less likely to die if the death probability is less than 0.5; otherwise, it is assumed to die with a high probability.
To further verify the feasibility of adopting the total expression of caspases 3, 6, and 7 as a measure of the chance of cell death, we compared the expression of these genes in βcells between healthy donors and T2D donors (Figs. 2e~2h). βcells control the secretion of insulin, which can maintain the homeostasis of glucose in blood. Several studies have shown that βcell deficit ranges from about 20% to 65% in patients with T2D [28, 29]. Student’s ttest was performed to show the differences in caspase expression levels between the two groups, with pvalue <0.05 taken as statistically significant. As shown in Figs. 2f~2h, the expression levels of caspase 6, 7, and the total caspase expression levels (caspases 3, 6, and 7) in βcells of the healthy group and the T2D group are significantly different. In addition, the individual and total expression levels of caspases 3, 6, and 7 of the healthy group are lower than those of the T2D group. Thus, the βcells of T2D donors are more vulnerable to cell death compared with the ones of the healthy donors. This is consistent with the βcell deficit facts in T2D. Thus, it is rational to use the total expression level of caspases 3, 6, and 7 in a cell to measure the likelihood of cell death.
Cell fate prediction based on correlation analysis
Singlecell gene expression data are available for 2209 cells. In this study, we adopted 10fold crossvalidation to evaluate the prediction of cell fate (in terms of cell death probability). Thus, the data of cells were randomly divided into ten equal sized subsets of cells. At each time of the crossvalidation, nine subsets of data were used for training, and the left one was used for testing. This process was repeated for 10 times (each subset of data is exactly used once as testing data) as one 10fold crossvalidation. Overall, we carried out the 10fold crossvalidation for 10 times, and as such generated 100 simulation results. In other words, we refined a total of 100 cell fate prediction functions, producing 100 prediction results. Then a single estimation of prediction accuracy was obtained by computing the average value of the 100 prediction results. Specific to the prediction accuracy of the tested cells, we compared the predicted cell death probability with the actual one of each cell. If both the values fell in the same interval ([0, 0.5) or [0.5, 1]), it was considered as a correct prediction; otherwise, the prediction was incorrect. Then the prediction accuracy of a testing dataset was derived by dividing the number of cells whose fates are correctly predicted by the total number of tested cells.
For each of the 2209 cells, the expression levels of 26,179 genes were measured. Thus, except for the marker genes (caspases 3, 6 and 7), a total of 26,176 genes can be used to conduct cell death prediction. However, not all of these genes are closely related to cell death. Hence, we first carried out a feature (gene) selection process to the cells used for training. Spearman’s rank correlation analysis was employed to extract genes that were highly related to cell death. Then, these genes were used as features of the training samples to refine the cell fate prediction function. We also extracted the corresponding genes of the testing cells, in order to make prediction. Figure 3a provides an example of the top 30 genes correlated with cell death from each training dataset. As the data used for training are different in each simulation, the derived top 30 genes may vary slightly among the training datasets. After conducting the 10fold crossvalidation for 10 times (100 times of training), 42 genes were extracted. Among them, 18 genes occur 100 times, i.e. they are repeatedly selected in the top 30 highly correlated genes from all the 100 training datasets. Several genes correlated to cell death are evidently related to apoptosis. For example, in chronic myeloid leukemia progenitor cells, RASEF was shown to induce apoptosis by activating caspases 3 and 9 [30]. Smith et al. reported that HSPB8 inhibits tumor growth by activating apoptosis pathways [31]. Zhang et al. demonstrated that PRSS8 promotes apoptosis and suppresses tumor growth in hepatocellular carcinoma [32]. In addition, evidence for the roles of LGALS9, LITAF and SH3BP4 in apoptosis has also been shown in the literature [33,34,35]. Except for these genes that are directly related to apoptosis, other genes may be involved in cell growth or other cellular processes. In fact, the functions of many genes and their roles in cellular processes are still not well known. Thus, not only does the correlation based method extract cell fate decision related genes, but it also provides clues for the genes’ functions if they are not completely understood.
We employed different degree polynomial models (linear, quadratic and cubic polynomials) to predict the cell fate. The function regress in MATLAB was called to conduct the regression analysis. We selected 5, 10, 30, 50, and 70 cell death related genes (according to the absolute values of Spearman’s correlation coefficients) from a training dataset. The prediction results are shown in Table 1 and Fig. 3b. Among the different combinations of models and selected genes, the highest prediction accuracy of 86.62% is achieved by the linear polynomial model on 10 genes. In consideration of genegene interactions, we also added cross terms to the quadratic polynomial model. The cross terms were chosen according to the Spearman’s correlation coefficients between gene pairs among the selected genes. We applied the top 10, 30, and 50 pairs of correlated genes in the quadratic polynomial model, respectively. The results are presented in Table 2 and Fig. 3c. Some prediction results are missing when there are too few genes to provide a specified number of gene pairs.
Prediction accuracy is just one performance measure of the models. We also evaluated the stability of different degree polynomial models in our work. Here, stability describes the resistance to changes of the model when different training data are applied. In our simulation, we conducted 10 times of 10fold crossvalidation for each setting of the models and the number of used genes (e.g. 10 genes used in linear polynomial model). Then, for one setting, a total of 100 regression functions were derived as the model was trained with 100 slightly different training datasets. On the one hand, we measured the variation ranges of the regression parameters of the 100 functions. On the other hand, we randomly selected 10,000 points (high dimensional points, with each dimension representing the expression level of one gene), and the regression values of each point can be obtained according to the regression functions. Then 100 regression values were generated for each point, as we simulated 100 times for each setting. Afterwards, the variance of the 100 regression values at each point can be derived. Overall, a total of 10,000 variances were obtained. We can draw the probability density function (PDF) and cumulative density function (CDF) of the variances to examine their distributions. Additionally, the mean value of all the variances (MVAV) could be used to measure the instability of the model, with the smaller value of MVAV denoting high stability. It should be clearly noted that we used the same set of randomly selected points when conducting stability analysis for different models with the same number of genes (e.g. 10 genes applied in both linear and quadratic polynomial models). Figures 4 and 5 present an example of the stability analysis. We adopted 10 genes to refine the linear, quadratic, and cubic polynomial models, as well as the quadratic polynomial model with 10 correlated gene pairs. As shown in Fig. 4, the parameter ranges of the linear polynomial model are the smallest, while the cubic polynomial model is the most volatile. In addition, the PDFs and CDFs show that the distribution of the variances associated with the linear polynomial model is very dense, and the values of the variances are much smaller (Fig. 5). Tables 1 and 2 provide the MVAV for each kind of setting. The linear polynomial model performs better than other order polynomial models (quadratic, cubic polynomials and quadratic polynomial with correlated gene pairs), when the number of applied genes is fixed (Fig. 3d and e).
Cell fate prediction by using genes in the apoptosis pathway
Besides selecting genes based on correlation analysis, we alternatively selected genes that are presented in the apoptosis pathway to predict cell fate. A total of 32 most common genes were used: APAF1, ATF4, BAK1, BAX, BCL2, BCL2L1, BID, CAPN1, CAPN2, CASP8, CASP9, CASP10, CYCS, DAXX, DDIT3, DIABLO, EIF2AK3, EIF2S1, ERN1, FADD, FAS, ITPR1, MAP3K5, MAPK8, MAPK9, MAPK10, MDM2, TNFRSF1A, TRADD, TRAF2, TP53, and XIAP (Fig. 6) [36]. We still applied the linear, quadratic, cubic polynomial models, and quadratic polynomial model with cross terms to refine the cell fate prediction function. 10fold crossvalidation was carried out for each setting. Compared with the correlation based gene selection, here the cross terms were derived from our knowledge of gene regulation. For example, TP53 regulates the transcription of MDM2, then the cross term of TP53×MDM2 was added into the cell fate prediction function. Overall, there are six cross terms. The prediction results are shown in Table 3 and Fig. 7a. The highest accuracy of 84.73% was achieved by the quadratic polynomial model with cross terms. We also analyzed the stability of the models against variation in regression parameters as well as the variances at randomly selected points (Figs. 7b, c and 8). Similarly, 10,000 randomly selected points were used. As the number of genes was fixed, the same set of stability testing points was employed for different degree polynomial models. As shown in Fig. 7b and c, the distribution of variances of the randomly selected points associated with the linear model is very dense, and the values of the variances are much smaller. In Fig. 8, the regression parameters of linear polynomial model are in the smallest fluctuation ranges.
Discussion
Cell fate decision is very important, as over proliferation or excessive death of cells may lead to various kinds of human diseases. We aim to build models to predict the death probability of a cell based on its gene expression data. A continuous model for steady state data may be suitable for this purpose. A linear model (PLS regression method) was implied in [19, 20] to relate cancer cell phenotypes with the protein activity levels. Although the data were measured at several time points, the linear model can be used to predict phenotypic response at each time point as well. However, a linear model tends to be considered too simple to handle the scenarios of cross talk or feedback in signaling pathways. For the same data set as [20], the authors of [21] proposed an exponential model, which showed better performance in predicting cell death than a linear model. The protein activity levels in [20] were expressed as the fold changes compared with the control samples. Essentially, after a log transformation of the data (protein activity levels), the exponential model becomes a linear one. In practice, a log transformation for the protein activity data was sometimes conducted when performing statistical analysis [37,38,39]. In our study, we used singlecell gene expression data obtained from [22], in which the RNAseq method was used to measure the gene expression levels, and the results were reported in reads per kilobase per million mapped reads (RPKM). Typically, a log transformation is necessary for the RPKM data. In one aspect, the gene expression dataset tends to be substantially skewed, but often being logtransformed it can approximate the normal distribution. Moreover, log transformation makes the data more symmetrical, providing much convenience for both direct observation and statistical tests. Thus, the model in [21] is actually linear for our logtransformed gene expression data.
In this work, we intend to find the relationship between singlecell gene expression data and cell fate decision. It is well known that a function can be expressed as a Taylor series under the condition of being infinitely differentiable at a fixed point. We employed this idea and directly used polynomials to represent the cell fate prediction function. The variables of the function are expression levels of specific genes. The genes were selected in two ways, using a correlation based approach and an apoptosis pathway based method. The selected genes could refine the cell fate prediction function in different degree polynomial models (linear, quadratic, cubic polynomial models, and quadratic polynomial model with cross terms of correlated gene pairs). 10fold crossvalidation was carried out for model validation. In addition, we analyzed the stability of each model by evaluating the ranges of the parameters, as well as assessing the variances of the predicted values at some randomly selected points. In the scenario of gene selection based on correlation analysis, the prediction accuracies (about 84%~86%) of different degree polynomial models do not show much difference. However, linear regression model performed the best in the stability analysis when the same number of genes was used to refine the prediction functions (Tables 1 and 2). Take the number of 10 applied genes as an example (Figs. 4 and 5). The parameters of the linear regression model vary in a smaller scale compared with those of other degree polynomial regression models. In addition, the PDFs of different models show that the 10,000 variances (corresponding to a total of 10,000 tested points) of the linear model are much smaller and the distribution is very dense. The same situation occurs when genes are selected from the apoptosis pathway. Then we compared the performance of the models based on the results of the two gene selection methods. Although the prediction accuracy of the model based on correlation analysis outcomes can achieve 86.62%, higher than the best accuracy of the pathway based method, the models composed of genes from the apoptosis pathway are more stable (comparison of the same degree polynomial models, Tables 1~3). The difference in the stability may be caused by the genes used in regression. In each training process (to learn the cell fate prediction function), the involved genes may be slightly different if the correlation based method is used, but the same set of genes is employed when using the apoptosis pathway based approach.
As discussed above, the prediction accuracies of the polynomial model of different degrees show little difference, but the linear polynomial model performed the best in terms of stability. To further analyze the behavior of a biochemical system, it is desirable to explore the theoretical description of the chemical reactions [40,41,42,43].
Conclusions
In this study, we proposed a polynomial based model to predict cell fate. To refine the prediction function, genes were selected by using a correlation analysis approach as well as an apoptosis pathway based method. We employed different degree polynomials to refine the cell fate prediction function from singlecell gene expression data of human pancreatic cells. Using the two gene selection methods, the prediction accuracies of different degree polynomial models are very close, but the linear regression model performs much more stable than others. When comparing the performance of linear regression model based on the results from the two gene selection methods, the prediction accuracy of the model with correlation analysis outcomes is a little higher (86.62% vs. 84.17%) than that of the model based on genes from the apoptosis pathway. However, the model with genes from the apoptosis pathway is more stable (3.1529e4 vs. 7.7577e4, MVAV). Thus, it is promising to use linear model to associate cell fate decision with gene expression data for the pancreatic cells. In addition, the genes in a specific pathway are preferred to conduct the regression process. This linear model could be extended to the cell fate prediction of other cells, and thereby facilitate research on human diseases caused by cell fate dysregulation.
Abbreviations
 CDF:

Cumulative density function
 MVAV:

Mean value of all the variances
 PDF:

Probability density function
 PLS:

Partial least squares
 RPKM:

Reads per kilobase per million mapped reads
 T2D:

Type 2 diabetes
References
 1.
Morris SA, Daley GQA. Blueprint for engineering cell fate: current technologies to reprogram cell identity. Cell Res. 2013;23:33–48.
 2.
Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nat. 2001;411:342–8.
 3.
Torre LA, Bray F, Siegel RL, Ferlay J, LortetTieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108.
 4.
Chiong M, Wang Z, Pedrozo Z, Cao D, Troncoso R, Ibacache M, et al. Cardiomyocyte death: mechanisms and translational implications. Cell Death Dis. 2011;2:e244.
 5.
Knaapen MW, Davies MJ, De Bie M, Haven AJ, Martinet W, Kockx MM. Apoptotic versus autophagic cell death in heart failure. Cardiovasc Res. 2001;51:304–12.
 6.
Mattson MP. Apoptosis in neurodegenerative disorders. Nat Rev Mol Cell Biol. 2000;1:120–30.
 7.
Lin MT, Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nat. 2006;443:787–95.
 8.
Luedde T, Kaplowitz N, Schwabe RF. Cell death and cell death responses in liver disease: mechanisms and clinical relevance. Gastroenterology. 2014;147:765–83.
 9.
Meier JJ, Bonadonna RC. Role of reduced βcell mass versus impaired βcell function in the pathogenesis of type 2 diabetes. Diabetes Care. 2013;36:113–9.
 10.
Rhodes CJ. Type 2 diabetesa matter of ßcell life and death? Sci. 2005;307:380–4.
 11.
MacArthur BD, Ma'ayan A, Lemischka IR. Systems biology of stem cell fate and cellular reprogramming. Nat Rev Mol Cell Biol. 2009;10:672–81.
 12.
Fisher J, Henzinger TA. Executable cell biology. Nat Biotechnol. 2007;25:1239–49.
 13.
Ganguly R, Puri I. Mathematical model for the cancer stem cell hypothesis. Cell Prolif. 2006;39:3–14.
 14.
Spencer SL, Sorger PK. Measuring and modeling apoptosis in single cells. Cell. 2011;144:926–39.
 15.
Calzone L, Tournier L, Fourquet S, Thieffry D, Zhivotovsky B, Barillot E, et al. Mathematical modelling of cellfate decision in response to death receptor engagement. PLoS Comput Biol. 2010;6:3.
 16.
Zinovyev A, Fourquet S, Tournier L, Calzone L, Barillot E. Cell death and life in cancer: mathematical modeling of cell fate decisions, In Advances in Systems Biology. Springer. 2012:261–74.
 17.
Tyson JJ, Baumann WT, Chen C, Verdugo A, Tavassoly I, Wang Y, et al. Dynamic modelling of oestrogen signalling and cell fate in breast cancer cells. Nat Rev Cancer. 2011;11:523–32.
 18.
Bhattacharya S, Zhang Q, Andersen MEA. Deterministic map of Waddington's epigenetic landscape for cell fate specification. BMC Syst Biol. 2011;5:85.
 19.
Janes KA, Albeck JG, Gaudet S, Sorger PK, Lauffenburger DA, Yaffe MB. A systems model of signaling identifies a molecular basis set for cytokineinduced apoptosis. Sci. 2005;310:1646–53.
 20.
Lee MJ, Albert SY, Gardino AK, Heijink AM, Sorger PK, MacBeath G, et al. Sequential application of anticancer drugs enhances cell death by rewiring apoptotic signaling networks. Cell. 2012;149:780–94.
 21.
Zhang F, Kwoh CK, Wu M, Zheng J. Datadriven prediction of cancer cell fates with a nonlinear model of signaling pathways. In Proceedings of the 5th ACM Conference on Bioinformatics, Computational Biology, and Health Informatics. ACM. 2014:436–44.
 22.
Segerstolpe Å, Palasantza A, Eliasson P, Andersson EM, Andréasson AC, Sun X, et al. Singlecell transcriptome profiling of human pancreatic islets in health and type 2 diabetes. Cell Metab. 2016;24:593–607.
 23.
Spearman C. The proof and measurement of association between two things. Am J Psychol. 1904;15:72–101.
 24.
Chatterjee S, Hadi AS. Influential observations, high leverage points, and outliers in linear regression. Stat Sci. 1986:379–93.
 25.
Pertea M, Salzberg SL. Between a chicken and a grape: estimating the number of human genes. Genome Biol. 2010;11:206.
 26.
Zaret KS, Grompe M. Generation and regeneration of cells of the liver and pancreas. Sci. 2008;322:1490–4.
 27.
Edlund H. Pancreatic organogenesisdevelopmental mechanisms and implications for therapy. Nat Rev Genet. 2002;3:524–32.
 28.
Butler AE, Janson J, BonnerWeir S, Ritzel R, Rizza RA, Butler PC. βcell deficit and increased βcell apoptosis in humans with type 2 diabetes. Diabetes. 2003;52:102–10.
 29.
Rahier J, Guiot Y, Goebbels R, Sempoux C, Henquin JC. Pancreatic βcell mass in European subjects with type 2 diabetes. Diabetes Obes Metab. 2008;10:32–42.
 30.
Nakamura S, Takemura T, Tan L, Nagata Y, Yokota D, Hirano I, et al. Small GTPase RAB45mediated p38 activation in apoptosis of chronic myeloid leukemia progenitor cells. Carcinogenesis. 2011;32:1758–72.
 31.
Smith C, Lee K, Li B, Laing J, Hersl J, Shvartsbeyn M, et al. Restored expression of the atypical heat shock protein H11/HspB8 inhibits the growth of genetically diverse melanoma tumors through activation of novel TAK1dependent death pathways. Cell Death Dis. 2012;3:e371.
 32.
Zhang L, Jia G, Shi B, Ge G, Duan H, Yang Y. PRSS8 is downregulated and suppresses tumour growth and metastases in hepatocellular carcinoma. Cell Physiol Biochem. 2016;40:757–69.
 33.
Fujita K, Iwama H, Oura K, Tadokoro T, Samukawa E, Sakamoto T, et al. Cancer therapy due to apoptosis: Galectin9. Int J Mol Sci. 2017;18:74.
 34.
Zou J, Guo P, Lv N, Huang D. Lipopolysaccharideinduced tumor necrosis factorα factor enhances inflammation and is associated with cancer. Mol Med Report. 2015;12:6399–404.
 35.
Kim YM, Stone M, Hwang TH, Kim YG, Dunlevy JR, Griffin TJ, et al. SH3BP4 is a negative regulator of amino acidrag GTPasemTORC1 signaling. Mol Cell. 2012;46:833–46.
 36.
Apoptosis, KEGG Pathway Database. http://www.kegg.jp/keggbin/highlight_pathway?scale=1.0&map=map04210&keyword=apoptosis. Accessed 15 Mar 2017.
 37.
Zhao J, O'Donnell VB, Balzar S, Croix CMS, Trudeau JB, Wenzel SE. 15lipoxygenase 1 interacts with phosphatidylethanolaminebinding protein to regulate MAPK signaling in human airway epithelial cells. Proc Natl Acad Sci. 2011;108:14246–51.
 38.
Kauko O, Laajala TD, Jumppanen M, Hintsanen P, Suni V, Haapaniemi P, et al. Labelfree quantitative phosphoproteomics with novel pairwise abundance normalization reveals synergistic RAS and CIP2A signaling. Sci Rep. 2015;5:13099.
 39.
Degasperi A, Birtwistle MR, Volinsky N, Rauch J, Kolch W, Kholodenko BN. Evaluating strategies to normalise biological replicates of western blot data. PLoS One. 2014;9:1–11.
 40.
Hill AV. The possible effects of the aggregation of the molecules of haemoglobin on its dissociation curves. J Physiol Lond. 1910;40:4–7.
 41.
Weiss JN. The hill equation revisited: uses and misuses. FASEB J. 1997;11:835–41.
 42.
Gesztelyi R, Zsuga J, KemenyBeke A, Varga B, Juhasz B, Tosaki A. The hill equation and the origin of quantitative pharmacology. Arch Hist Exact Sci. 2012:427–38.
 43.
Stefan MI, Le Novère N. Cooperative binding. PLoS Comput Biol. 2013;9:1–6.
Acknowledgements
Not applicable.
Funding
This work is supported by MOE AcRF Tier 1 grant (2015T1–002094), Ministry of Education, Singapore.
The publication cost is supported by MOE AcRF Tier 1 grant (2015T1–002094), Ministry of Education, Singapore.
Availability of data and materials
All data generated or analyzed during this study are included in this published article.
About this supplement
This article has been published as part of BMC Systems Biology Volume 11 Supplement 7, 2017: 16th International Conference on Bioinformatics (InCoB 2017): Systems Biology. The full contents of the supplement are available online at https://bmcsystbiol.biomedcentral.com/articles/supplements/volume11supplement6.
Author information
Affiliations
Contributions
LM built the polynomial model of cell fate prediction, performed model analysis, and drafted the manuscript. JZ initiated the project, participated in the design of the study, and helped draft the manuscript. Both authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
Not applicable. We used a published dataset in this article.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Ma, L., Zheng, J. A polynomial based model for cell fate prediction in human diseases. BMC Syst Biol 11, 126 (2017). https://doi.org/10.1186/s1291801705025
Published:
Keywords
 Cell fate prediction
 Cell death
 Mathematical modeling
 Polynomial
 Apoptosis pathway
 Correlation analysis
 Singlecell gene expression